Federated Hermes Inc. Purchases 11,652 Shares of Humana Inc. (NYSE:HUM)

Federated Hermes Inc. raised its holdings in shares of Humana Inc. (NYSE:HUM) by 37.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,651 shares of the insurance provider’s stock after purchasing an additional 11,652 shares during the period. Federated Hermes Inc.’s holdings in Humana were worth $15,937,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. CarsonAllaria Wealth Management Ltd. lifted its holdings in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares during the period. Hantz Financial Services Inc. bought a new position in shares of Humana in the 2nd quarter worth $35,000. Family Firm Inc. acquired a new stake in shares of Humana during the second quarter worth $37,000. Carolinas Wealth Consulting LLC increased its holdings in Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares during the last quarter. Finally, Riverview Trust Co acquired a new position in Humana in the second quarter valued at about $44,000. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 2.0 %

Humana stock opened at $315.20 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a 50-day moving average of $363.00 and a 200-day moving average of $346.63. The company has a market cap of $37.95 billion, a price-to-earnings ratio of 19.63, a P/E/G ratio of 2.56 and a beta of 0.50. Humana Inc. has a one year low of $298.61 and a one year high of $530.54.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $8.94 EPS. On average, equities analysts expect that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.12%. Humana’s payout ratio is 22.04%.

Analyst Ratings Changes

A number of brokerages have recently commented on HUM. Truist Financial upped their price target on Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 target price on shares of Humana in a report on Tuesday, September 10th. Oppenheimer boosted their price target on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Morgan Stanley initiated coverage on Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective on the stock. Finally, TD Cowen boosted their target price on Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $398.70.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.